COFFI Cohort Summary table
Participating Cohorts
Chronic Fatigue following Acute EBV Infection in Adolescents (CEBA)
PI: Prof. Vegard Bruun Bratholm Wyller
Dept. of Paediatrics, Akershus University Hospital, Norway
✉ v.b.b.wyller@medisin.uio.no
https://pubmed.ncbi.nlm.nih.gov/30261303/
Dubbo Infection Outcome Study (DIOS)
PI: Prof. Andrew Lloyd
Viral immunology Systems Program, Kirby Institute, University of New South Wales, Australia
✉ a.lloyd@unsw.edu.au
https://pubmed.ncbi.nlm.nih.gov/16950834/
Auckland IM and Campylobacter gastroenteritis cohorts
PI: Prof. Rona Moss-Morris
Psychology and Neuroscience, King’s College London, UK
✉ rona.moss-morris@kcl.ac.uk
https://pubmed.ncbi.nlm.nih.gov/20663256/
Bergen Giardiasis cohort, Norway
PI: Dr Knut-Arne Wensaas,
Research unit for general practice, NORCE Norwegian Research Centre, Bergen, Norway
✉ knwe@norceresearch.no
https://pubmed.ncbi.nlm.nih.gov/25115874/
Dutch Q fever study (IMPAQT)
PI: Dr Ellen van Jaarsveld
Department of Primary and Community Care, Radboud University Medical Center, Nijmegen, The Netherlands
✉ jeannine.hautvast@radboudumc.nl
https://pubmed.ncbi.nlm.nih.gov/24468188/
Qure Study. Treatment of Q-fever fatigue syndrome with CBT vs doxycycline vs placebo
PIs: Prof. Chantal Bleeker-Rovers & Dr Stephan Keijmel
University of Amsterdam, The Netherlands
✉ stephan.keijmel@radboudumc.nl
https://pubmed.ncbi.nlm.nih.gov/28329131/
Askøy Campylobacter Outbreak Study (ASCOS)
PI: Prof Guri Rørtveit
Dept. of global public health and primary care, University of Bergen, Norway.
https://doi.org/10.1007/s15010-021-01652-3
Patient-reported outcomes and thromboembolism after COVID-19 without
hospitalization (PROTROM)
PI: Prof Knut Stavem
Akershus University Hospital, Norway
https://pubmed.ncbi.nlm.nih.gov/34028814/
Long term effects of COVID-19 in adolescents (LoTECA)
PI: Prof Vegard Bruun Bratholm Wyller
Dept. of Paediatrics and Adolescent Medicine, Akershus University Hospital, Norway
https://pubmed.ncbi.nlm.nih.gov/36995712/
ReCOVer - internet-based Cognitive Behavioural Therapy [iCBT] for severe fatigue after COVID-19
PI: Prof Hans Knoop
Department of Medical Psychology, Amsterdam Public Health Research Institute,
Meibergdreef 9, Amsterdam, Amsterdam UMC, University of Amsterdam.
LymeProspect study
PI: Dr Kees van den Wijngaard
RIVM, Centre for Infectious Disease Control, Epidemiology and Surveillance, Netherlands
✉ kees.van.den.wijngaard@rivm.nl
https://pubmed.ncbi.nlm.nih.gov/34557833/
TELECHIK/CHIKGENE
PI: Dr Patrick Gérardin
Research Center for Health and Medical Science, CHU Réunion
✉ patrick.gerardin@chu-reunion.fr
https://pubmed.ncbi.nlm.nih.gov/29486812/
RECoVERED study - Evolution of COVID-19 symptoms during the first 12
months after illness onset
PI: Prof Maria Prins
Public Health Service of Amsterdam and Amsterdam University Medical Centres (Location AMC)
https://pubmed.ncbi.nlm.nih.gov/34473245/
Prevalence and determinants of persistent symptoms after infection with SARS-CoV-2. (LongCOVID-study)
PI: Dr Tessa van der Maaden
RIVM, Centre for Infectious Disease Control, Epidemiology and Surveillance, Netherlands
✉ tessa.van.der.maaden@rivm.nl
https://www.medrxiv.org/content/10.1101/2022.01.10.22269009v1
Prospective Study of the Natural History of IM Caused by EBV
PI: Prof Dedra Buchwald
Institute for Research and Education to Advance Community Health, Washington State University, USA
https://pubmed.ncbi.nlm.nih.gov/15295705/
https://pubmed.ncbi.nlm.nih.gov/11789721/
https://pubmed.ncbi.nlm.nih.gov/11458965/
The Post-hospitalization COVID-19 study (PHOSP-COVID)
PI: Dr. Rachael Evans
Department of Respiratory Sciences, University of Leicester, UK.
https://pubmed.ncbi.nlm.nih.gov/34627560/